-
Who We Are
Overview
Sasol is a global chemicals and energy company. We harness our knowledge and expertise to integrate sophisticated technologies and processes into world-scale operating facilities. We safely and sustainably source, produce and market a range of high-quality products, creating value for stakeholders.
-
Our Businesses
Overview
Sasol comprises three distinct market-focused businesses, namely: Chemicals, Energy and Sasol ecoFT. Our more focused portfolio is underpinned by a transition to a lower-carbon future and our 70-year track record demonstrates we have the capabilities and competencies to deliver sustainable value in these three core businesses.
-
ESG
Overview
Advancing chemical and energy solutions that contribute to a thriving planet, society and enterprise.
-
Investor Centre
Overview
Sasol's investors consist of both equity investors (those invested in the Sasol ordinary shares or the ADRs) and lenders/debt investors (banks and institutional investors lending to Sasol or investing in its issues of debt instruments such as local bonds, offshore bonds, commercial paper issues, project finance, loans and other credit facilities and convertible instruments).
-
Suppliers
Overview
Supply Chain is the custodian of all external spend for the Sasol Group. It is responsible for managing supply and demand so as to ensure cost-efficiency and maximise return on spend, while at the same time ensuring effective logistics of a range of deliverables.
-
Careers
Overview
Explore existing opportunities to energise your career to the next level. Whether you are seeking a Learnership or you are Student or Graduate or Experienced Hire. Find out how you can add value to the Sasol Team.
-
Media Centre
Overview
Access media releases and view latest social media updates
Holiferm and Sasol Chemicals expand collaboration to develop and market sustainable surfactants
Holiferm and Sasol Chemicals expand collaboration to develop and market sustainable surfactants
Hamburg, Germany – Holiferm Limited and Sasol Chemicals, a business unit of Sasol Ltd. (JSE: SOL; NYSE: SSL), announced today a collaboration to produce and market rhamnolipids and mannosylerythritol lipids (MELs). This collaboration expands the partnership announced in March 2022 between the two companies to develop and commercialise another biosurfactant product, sophorolipids.
The partnership will use Holiferm’s proprietary technology to develop the fermentation-derived biosurfactants. Sasol and Holiferm will develop and commercialise formulations and applications for the new molecules.
Biosurfactants use natural materials to produce surfactants, which are key ingredients in detergents, cleaning products and personal care products. Sophorolipids, rhamnolipids and MELs are all glycolipids made through fermentation, using yeast or bacteria to convert vegetable oils and/or sugars into final product. The Holiferm process offers an extensive reduction in carbon footprint compared with conventional surfactants.
“The imminent commercial launch of our second and third products validates Holiferm’s process to develop process technologies to produce chemicals from natural raw materials and enable their broad commercialisation,” said Vicky De Groof, Chief Technical Officer of Holiferm. “It is also a testament to the exceptional work of the laboratory team.”
“By expanding our product portfolio from sophorolipids to include rhamnolipids and MELs, we aim to provide our customers a platform of solutions based solely on biosurfactants,” said Silke Hoppe, Vice President of Essential Care Chemicals for Sasol Chemicals. “Their carbon footprint as well as their mildness and high performance places these products in a leading position in today’s biosurfactant market.”
Since March 2022, Sasol and Holiferm have collaborated on research and development into accelerating innovation to help meet the growing demand for sustainable solutions in primary surfactants. This has now been expanded to include developing processes to manufacture rhamnolipids and MELs. The companies’ joint aspiration is to prepare for testing at pilot plant scale, before they begin a full manufacturing process at Holiferm’s Wallasey plant.